Advisory Services Network’s Quoin Pharmaceuticals QNRX Stock Holding History

Advisory Services Network’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$951	–	3125
2023 Q1	$951	Sell	5 -5	-50%	-$2.44K	﹤0.01%	3625
2022 Q4	$5.68K	Buy	+10	New	+$7.5K	﹤0.01%	3078
2020 Q4	–	Hold	0	–	-$2K	–	3629
2020 Q3	–	Hold	0	–	–	–	3169

Other funds holding QNRX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisory Services Network's QNRX Position: Q2 2023 in Review

Advisory Services Network sold out of Quoin Pharmaceuticals (QNRX) in Q2 2023, closing a stake of 5 shares — an estimated $951 sold.

Advisory Services Network first reported a position in QNRX in Q4 2022 and held it in 2 quarters. The position peaked at $5.68K in Q4 2022. 2 funds tracked by Wall St. Rank hold QNRX as of Q2 2023.

Advisory Services Network reported no remaining Quoin Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Advisory Services Network sold 5 Quoin Pharmaceuticals shares in Q2 2023, an estimated $951.
Advisory Services Network first reported a position in Quoin Pharmaceuticals in Q4 2022 and held it in 2 quarters.
Advisory Services Network's Quoin Pharmaceuticals position peaked at $5.68K in Q4 2022.
2 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.